EUVIMEDOpdag EUVIMED
Crossref

Reactive Oxygen Species-Responsive Dual Anti-Inflammatory and Antioxidative Nanoparticles for Anterior Uveitis

Dike Zhang, Jian He, Shi Yuan Hua, Yonghua Li, Min Zhou iD

ACS Applied Materials & Interfaces · 2024-04-24

DOI: 10.1021/acsami.4c00564 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, published online on 2024-04-24. Written by Dike Zhang and 4 co-authors. Institution: Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China. Major MEDLINE topics: Reactive Oxygen Species, Uveitis, Anterior, Nanoparticles, Dexamethasone. Cited 7 times so far (Crossref); 56 references. Funded by: Zhejiang University, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Anterior uveitis (AU) is an immune-mediated inflammatory disease that results in iritis, cyclitis, glaucoma, cataracts, and even a loss of vision. The frequent and long-term administration of corticosteroid drugs is limited in the clinic owing to the side effects and patient noncompliance with the drugs. Therefore, specifically delivering drugs to inflammatory anterior segment tissues and reducing the topical application dosage of the drug are still a challenge. Here, we developed dual dexamethasone (Dex) and curcumin (Cur)-loaded reactive oxygen species (ROS)-responsive nanoparticles (CPDC NPs) to treat anterior uveitis. The CPDC NPs demonstrated both anti-inflammatory and antioxidative effects, owing to their therapeutic characteristics of dexamethasone and curcumin, respectively. The CPDC NPs could effectively release dexamethasone and curcumin in the oxidizing physiological environment of the inflammation tissue. The CPDC NPs can effectively internalize by activated macrophage cells, subsequently suppressing the proinflammatory factor expression. Moreover, the CPDC NPs can inhibit ROS and inflammation via nuclear transcription factor E2-related factor 2/heme oxygenase-1 (Nrf2/HO-1) pathway activation. In an endotoxin-induced uveitis rabbit model, the CPDC NPs show a therapeutic effect that is better than that of either free drugs or commercial eye drops. Importantly, the CPDC NPs with a lower dexamethasone dosage could reduce the side effects significantly. Taken together, we believe that the dual-drug-loaded ROS-responsive NPs could effectively target and inhibit inflammation and have the potential for anterior uveitis treatment in clinical practice.

Subjects

MeSH terms (MEDLINE)

Reactive Oxygen SpeciesUveitis, AnteriorNanoparticlesDexamethasoneAnti-Inflammatory AgentsCurcuminAntioxidantsAnimalsRabbitsMiceRAW 264.7 CellsHumans

Author keywords

anterior uveitisanti-inflammatoryantioxidativenanoparticlesreactive oxygen species-responsive

Substances

Reactive Oxygen SpeciesDexamethasoneAnti-Inflammatory AgentsCurcuminAntioxidants

Authors and institutions

  • Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China.
  • Department of Ophthalmology, Jining Medical University Affiliated Hospital, Jining 272000, China.
  • Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute), Zhejiang University School of Medicine, Zhejiang University, Haining 314400, China.
  • Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
  • Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou 310053, China.

ORCID profiles: Min Zhou

Funding

  • Zhejiang University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang

Cite

APA

Zhang, D., He, J., Hua, S. Y., Li, Y., & Zhou, M. (2024). Reactive Oxygen Species-Responsive Dual Anti-Inflammatory and Antioxidative Nanoparticles for Anterior Uveitis. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c00564

Vancouver

Zhang D, He J, Hua SY, Li Y, Zhou M. Reactive Oxygen Species-Responsive Dual Anti-Inflammatory and Antioxidative Nanoparticles for Anterior Uveitis. ACS Applied Materials & Interfaces. 2024. doi:10.1021/acsami.4c00564

BibTeX
@article{Zhang2024,
  author = {Zhang, Dike and He, Jian and Hua, Shi Yuan and Li, Yonghua and Zhou, Min},
  title = {Reactive Oxygen Species-Responsive Dual Anti-Inflammatory and Antioxidative Nanoparticles for Anterior Uveitis},
  journal = {ACS Applied Materials & Interfaces},
  year = {2024},
  doi = {10.1021/acsami.4c00564}
}
Start for free →